Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Cash on Hand 2020–2023
Immuneering Corporation annual/quarterly cash on hand history from 2020 to 2023. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Immuneering Corporation cash on hand for the quarter ending December 31, 2023 were 59.4M, a 18.22% decrease year-over-year.
- Immuneering Corporation cash on hand for 2023 were 59.4M, a 18.22% decrease from 2022.
- Immuneering Corporation cash on hand for 2022 were 72.6M, a 3.01% decrease from 2021.
- Immuneering Corporation cash on hand for 2021 were 74.9M, a 101.91% increase from 2020.
- Immuneering Corporation cash on hand for 2020 were 37.1M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Immuneering Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2023 | $59 |
| 2022 | $73 |
| 2021 | $75 |
| 2020 | $37 |
| Immuneering Corporation Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2023-12-31 | $59 |
| 2022-12-31 | $73 |
| 2021-12-31 | $75 |
| 2020-12-31 | $37 |
Immuneering Corporation Cash on Hand — FAQ
Immuneering Corporation (IMRX) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's cash on hand history?
The chart and table above show Immuneering Corporation's cash on hand by year and by quarter, including the growth rate.